A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis
NCT03889509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63
Last updated 2022-08-19
Summary
This protocol is of a systematic review for risk factors of pulmonary arterial hypertension in systemic sclerosis.
Conditions
Sponsors & Collaborators
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Janet E Pope, MD MPH · St. Joseph's healthcare London
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2020-03-01
- Completion
- 2021-03-01
Countries
- Canada
Study Locations
More Related Trials
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Muscle Strength and Exercise Capacity in Sarcoidosis Patients
NCT00854672 ·Status: COMPLETED
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
NCT06885905 ·Status: RECRUITING
-
Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD
NCT03438032 ·Status: COMPLETED
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
Pulmonary Hypertension in Lymphangioleiomyomatosis
NCT00960895 ·Status: COMPLETED
-
In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients
NCT02556697 ·Status: TERMINATED ·Phase: NA
-
Emphysema and FLNA Mutation (E-FLNA)
NCT05550844 ·Status: COMPLETED
-
Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!
NCT01314807 ·Status: UNKNOWN
-
Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
NCT03008915 ·Status: COMPLETED ·Phase: PHASE2
-
Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 ·Status: COMPLETED
-
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
NCT01423071 ·Status: COMPLETED
-
Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension
NCT02594917 ·Status: COMPLETED
-
Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
NCT05482607 ·Status: RECRUITING
-
Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017
NCT03858842 ·Status: UNKNOWN
-
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
NCT02632123 ·Status: COMPLETED
-
Changes in Microcirculation and Functional Status During Exacerbation of COPD
NCT03250000 ·Status: UNKNOWN
-
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329 ·Status: RECRUITING
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
BRAIN, Symptoms, and Physical Activity in COPD
NCT04291131 ·Status: COMPLETED
-
Idiopathic Bronchiectasis and Pulmonary Hypertension
NCT03883048 ·Status: COMPLETED
-
68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis
NCT01321996 ·Status: TERMINATED ·Phase: PHASE4
-
Study of the Prevalence of Painful Symptoms of the Musculoskeletal System After Lung Transplantation
NCT03636802 ·Status: UNKNOWN
-
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World
NCT06728319 ·Status: ACTIVE_NOT_RECRUITING